Steffen Stürzebecher, a pharmacologist and experienced clinician, has been appointed chief medical officer of Adrenomed AG to help advance the company’s pivotal programme for an antibody for septic shock. He succeeds Jens Zimmermann who is retiring. Dr Stürzebecher was previously CMO at the Grünenthal Group as well as head of R&D portfolio management. He has also been CMO at Eisbach Bio GmbH, a German start-up investigating products targeting synthetic lethality in cancer. Dr Stürzebecher received a doctorate in medicine from the Faculty of Medicine at Freie Universität Berlin, Germany.
Adrenomed announced the appointment on 23 June 2022.
Copyright 2022 Evernow Publishing Ltd
